Cytokinetics makes a commitment to the climate and carries out its carbon assessment
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, they are developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
![](https://images.prismic.io/greenly/33ceefa8-4b0f-4962-a63a-6a78f7c57073_sporlab-XiZ7pRvCzro-unsplash.jpg?auto=compress%2Cformat&fit=max&w=604)
1998
Date of creation
424
Number of employees
2021
Year analyzed